Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.

Episode 26 December 07, 2022 00:39:02
Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.

Dec 07 2022 | 00:39:02

/

Show Notes

"Try to find the people who have a really strong background in regulatory science, who really understand the fundamentals, and who you believe can think creatively about the challenges of the cell therapy space." - Chris Min, Longeveron

Biorasi welcomes Chris Min to the Few & Far Between podcast for an inside look at the cell therapy industry and the importance of finding the right team to support your clinical trials. 

Other Episodes

Episode 51

April 03, 2025 00:55:05
Episode Cover

Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio

How do you turn back the epigenetic clock for humans and their animal companions?  Host Chris O'Brien welcomes Dan Oliver, CEO and Founder of...

Listen

Episode 30

May 23, 2023 00:35:12
Episode Cover

Episode 30, Part Two: Dr. Francisco Harrison, CEO and owner, Harrison CST Holding GmbH

"We have to rethink the sense of clinical research from the point of view that if we have the possibility to have markers that...

Listen

Episode 47

December 31, 2024 00:48:25
Episode Cover

Episode 47 - Marc Lajoie, CEO at Outpace Bio

"If you bring powerful technology to a problem that is well understood, then you can really make a difference." - Marc Lajoie, CEO at...

Listen